Preoperative Lymphocyte-to-monocyte Ratio and CA125 Level as Risk Factors for Advanced Ovarian Cancer
暂无分享,去创建一个
Mi Zhou | Fan Xu | Daniel Lin | Jun Li | Lihong Deng | Fang-Xiang Tang | Hui-Quan Hu | B. Su | Ya Tang | Ying-xiong Tang
[1] Shee-Uan Chen,et al. Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study , 2020, Reproductive Biology and Endocrinology.
[2] D. Lin,et al. Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer , 2020, Journal of Cancer.
[3] S. Ju,et al. Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125 , 2019, Journal of Ovarian Research.
[4] S. Moestrup,et al. Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression , 2019, The Journal of experimental medicine.
[5] Y. Huang,et al. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis , 2019, Journal of Ovarian Research.
[6] A. Piché,et al. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway , 2019, BMC cancer.
[7] N. Winer,et al. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review , 2019, Journal of Ovarian Research.
[8] Jae-Weon Kim,et al. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms , 2019, The New England journal of medicine.
[9] Zena Werb,et al. Roles of the immune system in cancer: from tumor initiation to metastatic progression , 2018, Genes & development.
[10] A. Jemal,et al. Ovarian cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[11] T. Morikawa,et al. LMR predicts outcome in patients after preoperative chemoradiotherapy for stage II-III rectal cancer. , 2018, The Journal of surgical research.
[12] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[13] Hongyan Wang,et al. The effect of CA125 on metastasis of ovarian cancer: old marker new function , 2017, Oncotarget.
[14] Yang Bai,et al. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer , 2017, Oncotarget.
[15] L. Puskás,et al. Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters , 2017, Mediators of inflammation.
[16] P. Goodfellow,et al. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target , 2017, Oncogene.
[17] Xipeng Wang,et al. Differential distribution of tumor-associated macrophages and Treg/Th17 cells in the progression of malignant and benign epithelial ovarian tumors , 2016, Oncology letters.
[18] Wang Min,et al. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. , 2016, The Journal of clinical investigation.
[19] J. Lee,et al. The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer , 2016, Journal of Cancer.